Incorporating immune cell surrogates into a full-thickness tissue equivalent of human skin to characterize dendritic cell activation.
Ontology highlight
ABSTRACT: In the past decades studies investigating the dendritic cell (DC) activation have been conducted almost exclusively in animal models. However, due to species-specific differences in the DC subsets, there is an urgent need for alternative in vitro models allowing the investigation of Langerhans cell (LC) and dermal dendritic cell (DDC) activation in human tissue. We have engineered a full-thickness (FT) human skin tissue equivalent with incorporated LC surrogates derived from the human myeloid leukemia-derived cell line Mutz-3, and DDC surrogates generated from the human leukemia monocytic cell line THP-1. Topical treatment of the skin models encompassing Mutz-LCs only with nickel sulfate (NiSO4) or 1-chloro-2,4-dinitrobenzene (DNCB) for 24 h resulted in significant higher number
SUBMITTER: Holken JM
PROVIDER: S-EPMC11615323 | biostudies-literature | 2024 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA